FTC, Memory-Booster Co. Spar Over Errors At 2nd. Circ.
Quincy Bioscience and the Federal Trade Commission have been sparring at the Second Circuit over how the company should handle fixing misstatements about a clinical trial for its contested memory booster Prevagen,...To view the full article, register now.
Already a subscriber? Click here to view full article